Gut & MicrobiomeGut Microbes Trigger Liver Signals That Limit Cancer and Gene Therapy Delivery
Gut bacteria may influence how effectively cancer treatments and gene therapies reach their targets. Researchers found that signals from gut microbes stimulate intestinal cells to produce serotonin, which activates immune cells in the liver. Those liver cells then remove therapeutic delivery vehicles from circulation. Temporarily blocking serotonin signaling, through receptor blockade or a dietary intervention, reduced this clearance. The authors report more than threefold therapeutic enhancement for chemotherapy and cancer treatments using viruses, plus fivefold to fifteenfold improvements for gene editing and messenger RNA therapies. These findings suggest a possible way to improve treatment delivery without redesigning the delivery vehicle itself. However, this summary relies on the abstract alone, which does not specify species, sample sizes, safety results, or dietary details. It does not support changing medications or diet.
